#TSP TruSpine Technologies PLC – Result of 2025 AGM December 10, 2025 – Posted in: TruSpine Plc (TSP)

TSP Advanced Technologies plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that at its 2025 AGM held earlier today all resolutions were duly passed. Details of the votes received will be available shortly on the Company’s website. The Directors of the Company are responsible for the release of this announcement. -END- TSP Investor Hub https://truspinetech.com/aqse-rule-4-14 TSP Advanced Technologies plc Tel: +44 (0)20 7118 0852 Geoff Miller, Non-executive Chairman Cairn…

TruSpine Technologies plc #TSP to be renamed TSP Advanced Technologies plc November 6, 2025 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that further to the announcement on 22 August 2025, its change of name from TruSpine Technologies plc to TSP Advanced Technologies plc has now been registered at Companies House and will become effective on the AQSE Exchange from 6 November 2025. The Company’s ticker for AQSE will remain as TSP. Following the change of name the Company’s website will be https://tspadvanced.com/ which…

TruSpine Technologies #TSP – Major Shareholding October 16, 2025 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies announces that Martin Armstrong and Cheam Marketing Consultants now own 9,741,333 shares (5.20%) of the company. Breakdown shown on TR1 form below: TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Truspine Technologies PLC 1b. Please…

#TSP TruSpine Technologies PLC – Subscription, Director/PDMR Dealing & RPT October 15, 2025 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it has raised gross proceeds of approximately £119,344 through a subscription (the “Subscription”) for 23,869,043 new ordinary shares of 0.01p each in the Company (“Subscription Shares”) at a price of 0.5 pence per share (the “Issue Price”). Use of Proceeds The net proceeds of the Subscription will be used to provide additional working capital for the Company as…

TruSpine Technologies #TSP – Final Results & Update re Suspension October 14, 2025 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the spinal (vertebral) stabilisation market, reports its full year results for the year ended 29 March 2025. Suspension Following publication of these results, the Company’s shares is anticipated to be restored to trading on the AQSE Growth Market with effect from 8:00a.m. on 15 October 2025 The Company continues to be in a pre-revenue development phase and remains loss-making at this stage of its…

#TSP TruSpine Technologies PLC – Delay to the publication of accounts & Suspension October 1, 2025 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces a delay to the completion and publication of its audited accounts for the year to 29 March 2025. Accordingly, pursuant to Rule 5.1 of the AQSE Growth Market Access Rulebook, a temporary suspension of trading in the Company’s shares will take effect from 08:00 today (1 October 2025). The Company anticipates that it will be in a position to publish…

TruSpine Technologies #TSP – Result of GM & Change of Name August 22, 2025 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that at its GM held earlier today all resolutions were duly passed. Change of Name Once the change of the Company’s name to TSP Advanced Technologies plc takes effect, the Company’s ticker for AQSE will remain as TSP. The Company’s new website address, containing the information required to be published pursuant to Rule 4.14 of the AQSE Growth Market Access…

#TSP TruSpine Plc – Issue of Warrant August 15, 2025 – Posted in: TruSpine Plc (TSP)

Issue of Warrant London, United Kingdom – 15 August 2025– TruSpine Technologies Plc, the medical device company focusedon the spinal (vertebral) stabilisation market, announces that, further to the Company’s previous announcements inrelation to its arrangements with Spartan Medical, Inc. (“Spartan”) and Proffitt Brothers Investments, LLC (“PBI”)announced on 28 April 2022 and 27 November 2023, the Board has now issued a warrant over 2,000,000 newordinary shares at an exercise price of 20 pence per share, expiring…

TruSpine Technologies #TSP – Notice of GM. Proposed Adoption of Bitcoin Treasury Policy, IP Expansion & Change of Name August 4, 2025 – Posted in: Blog, TruSpine Plc (TSP)

London, United Kingdom – 4 August 2025 – TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that the Company has sent a notice of general meeting (“GM”) to shareholders. The GM will be held at Regus, Crawley, Gatwick Airport Manor Royal, Churchill Court 3, Crawley, RH10 9LU on 22 August 2025 at 11:00 a.m. The Directors of TruSpine wish to seek shareholder approval for its recently announced decisions…

TruSpine #TSP – Engagement to support Bitcoin Treasury Policy July 3, 2025 – Posted in: Blog, TruSpine Plc (TSP)

London, United Kingdom – 3rd July, 2025 – TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it has engaged a fintech advisory company to provide support to the Board in the implementation of its Bitcoin Treasury Policy. The Company announced on 25th June that it was actively pursuing a Bitcoin Treasury Policy. In order to ensure that this is implemented in a best of breed fashion, achieves…

1
2
3
4
5
...
8
Next
Last »